Model 4965 Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Heart FailurePacingBradycardiaArrhythmia
Trial Locations (107)

Unknown

Birmingham

Anchorage

Phoenix

Scottsdale

Little Rock

Bakersfield

Chula Vista

Downey

East Palo Alto

Los Angeles

Salinas

Torrance

Van Nuys

Colorado Springs

Denver

Washington D.C.

Clearwater

Jacksonville

Melbourne

Ocala

Wellington

Atlanta

Columbus

Marietta

Oak Lawn

Indianapolis

Newburgh

Des Moines

Kansas City

Lexington

Louisville

Alexandria

Baton Rouge

Salisbury

Silver Spring

Towson

Grand Blanc

Marquette

Saginaw

Southfield

Robbinsdale

Rochester

Saint Paul

Kansas City

Lebanon

Browns Mills

Newark

Ocean City

Parlin

West Orange

Albuquerque

Mineola

Rochester

Greensboro

Hickory

Cincinnati

Cleveland

Columbus

Toledo

Portland

Doylestown

Lancaster

Sayre

Columbia

Florence

Sioux Falls

Chattanooga

Germantown

Memphis

Nashville

Amarillo

Austin

Dallas

Fort Worth

Houston

San Antonio

The Woodlands

Burlington

Chesapeake

Fairfax

Olympia

Spokane

Madison

Milwaukee

Bedford Park

Linz

Vienna

Hasselt

Calgary

Hamilton

Ottawa

Toronto

Montreal

Ste-Foy

Regina

Copenhagen

Marseille

Homburg/Saar

Catanzaro

Reggio Emilia

Udine

Eindhoven

Rotterdam

Belgrade

Valencia

Skövde

Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic

INDUSTRY

NCT01076348 - Model 4965 Post-Approval Study | Biotech Hunter | Biotech Hunter